Bristol-Myers Squibb
BMY
#200
Rank
NZ$178.26 B
Marketcap
NZ$87.57
Share price
-1.99%
Change (1 day)
-9.83%
Change (1 year)

Market capitalization of Bristol-Myers Squibb (BMY)

Market cap: NZ$178.26 Billion

As of December 2025 Bristol-Myers Squibb has a market cap of NZ$178.26 Billion. This makes Bristol-Myers Squibb the world's 200th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Bristol-Myers Squibb from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$178.26 B-14.06%
2024NZ$207.43 B25.65%
2023NZ$165.09 B-31.48%
2022NZ$240.94 B18.92%
2021NZ$202.61 B4.3%
2020NZ$194.26 B-8.52%
2019NZ$212.35 B68.74%
2018NZ$125.84 B-10.89%
2017NZ$141.22 B0.16%
2016NZ$140.99 B-15.54%
2015NZ$166.94 B34.05%
2014NZ$124.53 B17.34%
2013NZ$106.13 B64.36%
2012NZ$64.57 B-15.6%
2011NZ$76.51 B31.21%
2010NZ$58.31 B-1.85%
2009NZ$59.41 B-25.09%
2008NZ$79.31 B16.05%
2007NZ$68.34 B-6.76%
2006NZ$73.29 B11.4%
2005NZ$65.79 B-5.88%
2004NZ$69.90 B-18.1%
2003NZ$85.35 B-1.23%
2002NZ$86.41 B-64.14%
2001NZ$240.99 B-26.06%
2000NZ$325.93 B33.97%
1999NZ$243.29 B-3.64%
1998NZ$252.48 B55.9%
1997NZ$161.95 B109.8%
1996NZ$77.19 B

End of Day market cap according to different sources

On Dec 8th, 2025 the market cap of Bristol-Myers Squibb was reported to be:

NZ$181.97 Billion
by Nasdaq info icon info icon
NZ$181.88 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$252.04 B 41.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$416.90 B 133.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.545 T 766.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$438.63 B 146.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$203.90 B 14.39%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
NZ$484.67 B 171.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
NZ$842.37 B 372.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$680.20 B 281.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$295.63 B 65.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$45.53 B-74.46%๐Ÿ‡บ๐Ÿ‡ธ USA